Cat. No.: X24-08-YM107
DNA-RNA synthesis inhibitor, Bleomycin, Purity ≥98%
Synonym: 11056-06-7; Bleo; Bleocin; BLM; 3-[[2-[2-[2-[[(2S,3R)-2-[[(2S,3S,4R)-4-[[(2S,3R)-2-[[6-Amino-2-[(1S)-3-amino-1-[[(2S)-2,3-diamino-3-oxopropyl]amino]-3-oxopropyl]-5-methylpyrimidine-4-carbonyl]amino]-3-[3-[4-carbamoyloxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-(1H-imidazol-5-yl)propanoyl]amino]-3-hydroxy-2-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]ethyl]-1,3-thiazol-4-yl]-1,3-thiazole-4-carbonyl]amino]propyl-dimethylsulfanium
- CAS Number: 11056-06-7
- Compound CID: 5360373
Product Size
5 mg; 10 mg; 25 mg; 100 mg
Properties
Description
Bleomycin is an effective DNA damage inhibitor, that has the ability to prevent the pathway of DNA damage by inhibiting DNA-RNA synthesis.
Molecular Formula
C55H84N17O21S3
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Applications
Bleomycin is a DNA damage inhibitor that can be studied extensively for its potential therapeutic applications in the treatment of Hodgkin’s lymphoma, testicular cancer, and certain types of head and neck cancers.
Related Products
-
DNA-RNA synthesis inhibitor, Cidofovir, Purity ≥98%
-
DNA-RNA synthesis inhibitor, Clafen, Purity ≥98%
-
DNA-RNA synthesis inhibitor, Dacarbazine, Purity ≥98%
-
DNA-RNA synthesis inhibitor, Daptomycin, Purity ≥98%
-
DNA-RNA synthesis inhibitor, Gemcitabine HCl, Purity ≥98%
-
DNA-RNA synthesis inhibitor, Ifosfamide, Purity ≥98%
